中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 6
Jun.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(6): 1314-1318

Value of liver/spleen stiffness combined with serum adenosine deaminase in predicting severe esophageal varices in patients with hepatitis B cirrhosis

DOI: 10.3969/j.issn.1001-5256.2021.06.020

  • Department of Infectious Diseases, Changsha First Hospital, Changsha 410000, China

  • Received Date: 2020-10-31
  • Accepted Date: 2020-12-02
  • Published Date: 2021-06-20
    Abstract
  •   Objective  To investigate the value of liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) based on FibroTouch (FT) transient elastography combined with serum adenosine deaminase (ADA) in predicting severe esophageal varices (EV) in patients with hepatitis B cirrhosis.  Methods  Related clinical data were collected from 120 patients with hepatitis B cirrhosis who attended Department of Infectious Diseases, Changsha First Hospital, from December 2017 to June 2020. FT was used to measure LSM and SSM, and related examinations were performed, including electronic gastroscopy and serum levels of ADA, hemoglobin, albumin, alanine aminotransferase, and aspartate aminotransferase and platelet count. The serum liver fibrosis markers aspartate aminotransferase-to-platelet ratio index (APRI), aspartate aminotransferase/alanine aminotransferase ratio (AAR), and fibrosis-4 (FIB-4) were calculated. According to the severity of EV under gastroscopy, the subjects were divided into severe EV group with 58 patients and non-severe EV (without EV or with mild-to-moderate EV) group with 62 patients. The t-test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. The Spearman rank correlation test was used to investigate the correlation of LSM, SSM, and ADA with severe EV. The receiver operating characteristic (ROC) curve was used to analyze the efficacy of LSM, SSM, and ADA in the diagnosis of severe EV, and sensitivity and specificity were calculated. A multivariate binary logistic regression analysis was performed to calculate the area under the ROC curve (AUC) of the combined indicators, and the Z test was used for comparison of AUC.  Results  There were significant differences in LSM, SSM, and ADA between the two groups (all P < 0.05). LSM, SSM, and ADA were positively correlated with severe EV, with a correlation coefficient of 0.686, 0.743, and 0.723, respectively (all P < 0.05). The optimal cut-off value was 22.35 kPa for LSM, 45.25 kPa for SSM, and 34.50 U/L for ADA in predicting severe EV, with an AUC of 0.746, 0.802, and 0.791, respectively, a sensitivity of 82.8%, 75.9%, and 58.6%, respectively, and a specificity of 65.6%, 77.4%, and 90.2%, respectively. LSM+ADA, SSM+ADA, and LSM+SSM+ADA had an AUC of 0.826, 0.853, and 0.907, respectively, in predicting severe EV (all P < 0.05).  Conclusion  Liver/spleen stiffness combined with serum ADA has a good value in predicting severe EV, which can provide a preliminary diagnostic basis for severe EV in patients who refuse to undergo gastroscopy.

     

    • FullText(HTML)
  • loading
    • References(24)
  • [1]
    TSENG Y, LI F, WANG J, et al. Spleen and liver stiffness for noninvasive assessment of portal hypertension in cirrhotic patients with large esophageal varices[J]. J Clin Ultrasound, 2018, 46(7): 442-449. DOI: 10.1002/jcu.22635.
    [2]
    CASTÉRA L, LE BAIL B, ROUDOT-THORAVAL F, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores[J]. J Hepatol, 2009, 50(1): 59-68. DOI: 10.1016/j.jhep.2008.08.018.
    [3]
    BUECHTER M, KAHRAMAN A, MANKA P, et al. Spleen and liver stiffness is positively correlated with the risk of esophageal variceal bleeding[J]. Digestion, 2016, 94(3): 138-144. DOI: 10.1159/000450704.
    [4]
    STEFANESCU H, PROCOPET B, PLATON-LUPSOR M, et al. Is there any place for spleen stiffness measurement in portal hypertension?[J]. Am J Gastroenterol, 2013, 108(10): 1660-1661. DOI: 10.1038/ajg.2013.239.
    [5]
    SUN HY, WANG YJ, WANG M, et al. Liver biopsy results of chronic HBV carriers aged above 40 years: An analysis of 442 cases[J]. J Clin Hepatol, 2017, 33(8): 1479-1482. DOI: 10.3969/j.issn.1001-5256.2017.08.013.

    孙海英, 王雅君, 王明, 等. 442例40岁以上慢性HBV携带者肝穿刺活组织检查的结果分析[J]. 临床肝胆病杂志, 2017, 33(8): 1479-1482. DOI: 10.3969/j.issn.1001-5256.2017.08.013.
    [6]
    LI M, LI T, LIU ZJ, et al. Establishment and evaluation of a diagnostic modeI for liver fibrosis with the radio of serum markers as variables[J]. Shandong Med J, 2018, 58(18): 17-20. DOI: 10.3969/j.issn.1002-266X.2018.18.005.

    李曼, 李涛, 刘振杰, 等. 以血清学指标比值为变量的肝纤维化诊断模型构建与评价[J]. 山东医药, 2018, 58(18): 17-20. DOI: 10.3969/j.issn.1002-266X.2018.18.005.
    [7]
    KE YF, GAO GS, ZHU Z, et al. Value of serum adenosine deaminase in diagnosis of marked liver fibrosis in patients with chronic hepatitis B virus infection[J]. J Clin Hepatol, 2018, 34(4): 760-763. DOI: 10.3969/j.issn.1001-5256.2018.04.013.

    柯叶芳, 高国生, 朱喆, 等. 血清腺苷脱氨酶对慢性HBV感染者显著肝纤维化的诊断价值[J]. 临床肝胆病杂志, 2018, 34(4): 760-763. DOI: 10.3969/j.issn.1001-5256.2018.04.013.
    [8]
    KOTANI K, KAWABE J, MORIKAWA H, et al. Comprehensive screening of gene function and networks by DNA microarray analysis in Japanese patients with idiopathic portal hypertension[J]. Mediators Inflamm, 2015, 2015: 349215. DOI: 10.1155/2015/349215.
    [9]
    YANG YG, MA SH, LI FJ, et al. The clinical value of adenosine deaminase for diagnose of chronic viral hepatitis[J]. J Clin Hepatol, 2007, 23(1): 17-18. DOI: 10.3969/j.issn.1001-5256.2007.01.007.

    杨彦改, 马士恒, 李福建, 等. 腺苷脱氨酶在慢性病毒性肝病中的诊断价值研究[J]. 临床肝胆病杂志, 2007, 23(1): 17-18. DOI: 10.3969/j.issn.1001-5256.2007.01.007.
    [10]
    MA SH, YANG YG, CHANG YQ, et al. Study of the serum adenosine deaminase level in patients with hepatitis[J]. 2013, 30(1): 33-35. DOI: 10.3969/j.issn.1674-490X.2013.01.010.

    马士恒, 杨彦改, 常亚青, 等. 肝病患者血清腺苷脱氨酶检测的临床意义[J]. 医学研究与教育, 2013, 30(1): 33-35. DOI: 10.3969/j.issn.1674-490X.2013.01.010.
    [11]
    DENG H, QI X, GUO X. Diagnostic accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in predicting the presence of esophageal varices in liver cirrhosis: A systematic review and Meta-analysis[J]. Medicine (Baltimore), 2015, 94(42): e1795. DOI: 10.1097/MD.0000000000001795.
    [12]
    Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10. 3969 / j. issn. 1001 -5256. 2019. 12. 007.

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10. 3969 / j. issn. 1001-5256. 2019. 12. 007.
    [13]
    Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Gastroenterology, Chinese Medical Association; Chinese Society of Endoscopy, Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding incirrhotic portalhy pertension[J]. J Clin Hepatol, 2016, 32(2): 203- 219. DOI: 10.3969/j.issn.1001-5256.2016.02.002.

    中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2016, 32(2): 203-219. DOI: 10.3969/j.issn.1001-5256.2016.02.002.
    [14]
    ASRANI SK, DEVARBHAVI H, EATON J, et al. Burden of liver diseases in the world[J]. J Hepatol, 2019, 70(1): 151-171. DOI: 10.1016/j.jhep.2018.09.014.
    [15]
    KIM BK, HAN KH, PARK JY, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis[J]. Am J Gastroenterol, 2010, 105(6): 1382-1390. DOI: 10.1038/ajg.2009.750.
    [16]
    GARCIA-TSAO G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis[J]. Dig Dis, 2016, 34(4): 382-386. DOI: 10.1159/000444551.
    [17]
    GUO YL, LU XL, CHENG Y, et al. Combination measurement of liver and spleen stiffness with portal vein width to evaluate risk of bleeding in esophageal and gastric varices patients[J]. Chin J Hepatol, 2016, 24(1): 56-61. DOI: 10.3760/cma.j.issn.1007-3418.2016.01.011.

    郭芸蕾, 鲁晓岚, 程妍, 等. 肝脾硬度联合门静脉宽度评估肝硬化食管胃底静脉曲张出血风险[J]. 中华肝脏病杂志, 2016, 24(1): 56-61. DOI: 10.3760/cma.j.issn.1007-3418.2016.01.011.
    [18]
    YANG XP. Application value of liver and spleen stiffness detected by transient elastography for predicting esophageal varices[J]. Chin J Ultrasound Med, 2017, 33(2): 139-142. DOI: 10.3969/j.issn.1002-0101.2017.02.014.

    杨学平. 瞬时弹性成像检测肝脾硬度预测食管静脉曲张的价值[J]. 中国超声医学杂志, 2017, 33(2): 139-142. DOI: 10.3969/j.issn.1002-0101.2017.02.014.
    [19]
    FRAQUELLI M, GIUNTA M, POZZI R, et al. Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis[J]. J Viral Hepat, 2014, 21(2): 90-98. DOI: 10.1111/jvh.12119.
    [20]
    SINGH S, EATON JE, MURAD MH, et al. Accuracy of spleen stiffness measurement in detection of esophageal varices in patients with chronic liver disease: Systematic review and meta-analysis[J]. Clin Gastroenterol Hepatol, 2014, 12(6): 935-945. e4. DOI: 10.1016/j.cgh.2013.09.013.
    [21]
    COLECCHIA A, COLLI A, CASAZZA G, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: A prospective study[J]. J Hepatol, 2014, 60(6): 1158-1164. DOI: 10.1016/j.jhep.2014.02.024.
    [22]
    BEN-SHOSHAN SO, KAGAN P, SULTAN M, et al. ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis[J]. RNA Biol, 2017, 14(5): 587-602. DOI: 10.1080/15476286.2016.1203501.
    [23]
    LI XK. Analysis of serum biochemical indexes in 117 patients with liver cirrhosis[J]. Chin J Lab Diagn, 2016, 20(10): 1673-1675. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD201610020.htm

    李祥坤. 117例肝硬化患者血清多项生化指标的检测水平分析[J]. 中国实验诊断学, 2016, 20(10): 1673-1675. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD201610020.htm
    [24]
    JIANG ZG, SANDHU B, FELDBRVGGE L, et al. Serum activity of macrophage-derived adenosine deaminase 2 is associated with liver fibrosis in nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2018, 16(7): 1170-1172. DOI: 10.1016/j.cgh.2017.11.028.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (576) PDF downloads(61) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return